ClinicalTrials.gov
public full text
Public Domain
Laparoscopic Sleeve Gastrectomy With and Without Omentectomy
* The investigators aim to determine the clinical and metabolic effects of sleeve gastrectomy with or without omentectomy in the treatment of morbid obesity. * The investigators hypothesize that the endocrine suppression of ghrelin (appetite hormone)and resistin (insulin antagonist) provided by sleeve gastrectomy and omentectomy (omentum or intra-abdominal fat removal) will provide clinical and metabolic benefits for morbidly obese patients.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Istmin Levels in Laparoscopik Sleeve Gastrectomy#1033239
- Single Anastomosis Duodenal Ileal Bypass (SADI) for Sleeve Revision#812293
- Sleeve Gastrectomy Versus Gastric Bypass for Private Pay Patients Seeking Obesity Surgery#917946
- Biometabolic Outcomes After Weight Loss Surgery: An Individualized Approach#1095282
- the Related Factors of Bariatric Surgery on Liver Function#1029934
Record · ID 910931
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive